Effexor
NDC Package 0008-0833-22

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Effexor is venlafaxine is used to treat depression, anxiety, panic attacks, and social anxiety disorder (social phobia). Marketed by Wyeth Pharmaceuticals Llc, A Subsidiary Of Pfizer Inc., this product is identified by NDC 0008-0833 and is authorized under FDA application NDA020699.

Identification & Billing

NDC Package Code
0008-0833-22
Package Description
90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE
Product Code
11-Digit Billing Format
00008083322
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
90 EA
RxNorm Crosswalk
  • RxCUI: 313581 - venlafaxine HCl 150 MG 24HR Extended Release Oral Capsule
  • RxCUI: 313581 - 24 HR venlafaxine 150 MG Extended Release Oral Capsule
  • RxCUI: 313581 - venlafaxine (as venlafaxine HCl) 150 MG 24 HR Extended Release Oral Capsule
  • RxCUI: 313583 - venlafaxine HCl 37.5 MG 24HR Extended Release Oral Capsule
  • RxCUI: 313583 - 24 HR venlafaxine 37.5 MG Extended Release Oral Capsule

Clinical Specifications

Proprietary Name
Effexor XR
Dosage Form
-
Usage Information
Venlafaxine is used to treat depression, anxiety, panic attacks, and social anxiety disorder (social phobia). It may improve your mood and energy level and may help restore your interest in daily living. It may also decrease fear, anxiety, unwanted thoughts, and the number of panic attacks. Venlafaxine is known as a serotonin-norepinephrine reuptake inhibitor (SNRI). It works by helping to restore the balance of certain natural substances (serotonin and norepinephrine) in the brain.

Regulatory & Marketing

Labeler Name
Wyeth Pharmaceuticals Llc, A Subsidiary Of Pfizer Inc.
FDA Application #
NDA020699
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
11-01-1997
End Marketing Date
10-31-2025
Listing Expiration
10-31-2025
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (0008-0833). Click a package code to view its specific billing and regulatory data.

100 BLISTER PACK in 1 CARTON / 1 CAPSULE, EXTENDED RELEASE in 1 BLISTER PACK (0008-0833-02)
15 CAPSULE, EXTENDED RELEASE in 1 BOTTLE
30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 0008-0833-22 identifies a specific commercial package of 90 capsule, extended release in 1 bottle of Effexor XR, labeled by Wyeth Pharmaceuticals Llc, A Subsidiary Of Pfizer Inc.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Wyeth Pharmaceuticals Llc, A Subsidiary Of Pfizer Inc. on November 01, 1997. The current certification is valid through October 31, 2025.

What are the primary indications for this medication?

Venlafaxine is used to treat depression, anxiety, panic attacks, and social anxiety disorder (social phobia). It may improve your mood and energy level and may help restore your interest in daily living. It may also decrease fear, anxiety, unwanted thoughts, and the number of panic attacks. Venlafaxine is known as a serotonin-norepinephrine reuptake inhibitor (SNRI). It works by helping to restore the balance of certain natural substances (serotonin and norepinephrine) in the brain.

How is this Wyeth Pharmaceuticals Llc, A Subsidiary Of Pfizer Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 00008083322. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 90 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (4-4-2)
0008-0833-22
11-Digit CMS (5-4-2)
00008-0833-22

Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.